晶科科技(601778.SH):擬作為投標牽頭方 參與烏茲別克斯坦光伏電站項目投標
格隆匯 2 月 5日丨晶科科技(601778.SH)公佈,公司擬作為投標牽頭方,與國家電力投資集團有限公司旗下的中國電力國際有限公司(“中電國際”)組成聯合體,共同參與烏茲別克斯坦光伏電站項目的投標。
該項目由烏茲別克斯坦國家電力股份有限公司(NEGU)、烏茲別克斯坦投資和外貿部(MIFT)以及烏茲別克斯坦能源部(MOE)聯合招標,分為三個單體項目,裝機規模合計不低於600MW。項目購電方為烏茲別克斯坦國家電力股份有限公司(NEGU)。此次擬投標的三個單體項目總投資額約6.51億美元,各方持股比例及項目融資方案尚未最終確定。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.